Companies: 10,638     total market cap: โ‚น12170.341 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Sangamo Therapeutics
SGMO
#8725
Rank
โ‚น14.99 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น44.55
Share price
-6.45%
Change (1 day)
-73.30%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech๐Ÿงฌ Genomics๐Ÿงฌ Gene therapy
Categories

Revenue for Sangamo Therapeutics (SGMO)

Revenue in 2025 (TTM): โ‚น2.81 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น2.95 Billion. In 2024 the company made a revenue of โ‚น4.95 Billion a decrease over the revenue in the year 2023 that were of โ‚น14.67 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sangamo Therapeutics from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น2.81 B-43.16%
2024 โ‚น4.95 B-66.2%
2023 โ‚น14.67 B59.3%
2022 โ‚น9.20 B11.78%
2021 โ‚น8.23 B-4.68%
2020 โ‚น8.64 B18.34%
2019 โ‚น7.30 B23.69%
2018 โ‚น5.90 B152.91%
2017 โ‚น2.33 B77.21%
2016 โ‚น1.31 B-49.86%
2015 โ‚น2.62 B-9.62%
2014 โ‚น2.90 B94.99%
2013 โ‚น1.49 B25.75%
2012 โ‚น1.18 B117.21%
2011 โ‚น0.54 B-41.45%
2010 โ‚น0.93 B-9.44%
2009 โ‚น1.02 B32.33%
2008 โ‚น0.77 B117.89%
2007 โ‚น0.35 B2.24%
2006 โ‚น0.34 B212.55%
2005 โ‚น0.11 B96.2%
2004 โ‚น56.95 M-51.5%
2003 โ‚น0.11 B-43.62%
2002 โ‚น0.20 B-11.64%
2001 โ‚น0.23 B47.11%
2000 โ‚น0.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Gilead Sciences
GILD
โ‚น2.612 T 88,374.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น288.38 B 9,664.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.231 T 109,317.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น904.28 B 30,518.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚น3.675 T 124,350.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 T 280,201.14%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น277.95 B 9,311.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.770 T 195,291.63%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com